戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 d with ruthenium tetroxide provided the seco ketoacid.
2 tion by one-carbon extension cycles of alpha-ketoacids.
3 yze the decarboxylation of a series of alpha-ketoacids.
4 oxyalkanes followed by carboxylation to beta-ketoacids.
5 mimics of peptide alpha-ketoesters and alpha-ketoacids.
6  and the degradation of branched-chain alpha-ketoacids.
7 tive amide-bond forming reactions with alpha-ketoacids.
8 cally enriched, side chain unprotected alpha-ketoacids.
9 phatic nitroalkenes, 1,3-diketones, and beta-ketoacids.
10 e Ugi 4-center-3-component reaction of gamma-ketoacids.
11 me family that oxidizes L-2-hydroxy acids to ketoacids.
12 n of aryl alkyl ketones to the corresponding ketoacids.
13 hat oxidizes (S)-alpha-hydroxyacids to alpha-ketoacids.
14 thway resulting in net carboxylation to beta-ketoacids.
15 anobacterial sunscreen, have identified beta-ketoacid 2 as an important intermediate that is produced
16 s but also transaminates Met and its cognate ketoacid 4-methyl-2-oxobutanoate.
17 le disruption associated with branched-chain ketoacid accumulation.
18 nhydrolyzable pTyr mimics that contain alpha-ketoacid, alpha-hydroxyacid, and methylenesulfonamide fu
19  and V/K varied substantially when different ketoacid and pyridine nucleotide substrates were used.
20 erium isotope effects were observed for poor ketoacid and pyridine nucleotide substrates, indicating
21 est yields were obtained when both the alpha-ketoacid and the N-hydroxylamino acid contained medium-s
22 pproximately 36 h) with a 1:2 ratio of alpha-ketoacids and 2 or 3 gave major yields of the alpha,alph
23                   A series of peptidyl alpha-ketoacids and alpha-ketoesters was synthesized and studi
24 ltienzyme complexes that decarboxylate alpha-ketoacids and catabolize glycine.
25 us supplemental essential amino acids and/or ketoacids and followed closely.
26  construction of bicyclic beta-lactones from ketoacids and implements the use of commercially availab
27 gulate the oxidation of branched-chain alpha-ketoacids and pyruvate.
28 tes of fatty acid biosynthesis) to release 3-ketoacids and that ShMKS1 subsequently catalyzes the dec
29  carboxylation of aliphatic epoxides to beta-ketoacids as illustrated by the reaction epoxypropane +
30         A focused library of bidentate alpha-ketoacid-based inhibitors has been screened against seve
31 he reoxidation of reduced MDH by the product ketoacid, benzoylformate.
32 then undergoes two consecutive sets of alpha-ketoacid chain elongation reactions to produce alpha-ket
33 s can use a pathway involving succinyl-CoA:3-ketoacid-CoA transferase and acetoacetyl-CoA synthetase
34 lets possessed high levels of succinyl-CoA:3-ketoacid-CoA transferase, an enzyme that forms acetoacet
35                               Succinyl-CoA:3-ketoacid coenzyme A transferase (SCOT), the mitochondria
36 ouples oxidative decarboxylation of an alpha-ketoacid cofactor to oxidative modification of its subst
37 d also produced relatively more hydroxy- and ketoacid compounds that have implications for the fresh-
38 me A-dependent oxidation of branched-chain 2-ketoacids coupled to the reduction of viologen dyes or f
39                           In contrast, the 3-ketoacid decarboxylase activity of ShMKS1, which belongs
40 The human mitochondrial branched-chain alpha-ketoacid decarboxylase/dehydrogenase (BCKD) is a heterot
41              By engineering selectivity of 2-ketoacid decarboxylases and screening for promiscuous al
42 ental and computational study here of a beta-ketoacid decarboxylation shows how the distinction betwe
43 -chain amino acid catabolism, branched-chain ketoacid dehydrogenase (BCKAD), in rat muscles.
44 nknown, the function of branched-chain alpha-ketoacid dehydrogenase (BCKAD), the rate-limiting enzyme
45                     The branched chain alpha-ketoacid dehydrogenase (BCKD) complex commits the BCAA t
46 ing to the genes of the branched-chain alpha-ketoacid dehydrogenase (BCKD) complex which are affected
47 rough inhibition of the branched-chain-alpha-ketoacid dehydrogenase (BCKD) complex, the rate-limiting
48 cy in the mitochondrial branched-chain alpha-ketoacid dehydrogenase (BCKD) complex.
49 previously that the rat branched-chain alpha-ketoacid dehydrogenase (BCKD) kinase is capable of autop
50 or of the mitochondrial branched-chain alpha-ketoacid dehydrogenase (BCKD) responsible for the rate-l
51  of human mitochondrial branched-chain alpha-ketoacid dehydrogenase (BCKD), chaperonins GroEL/GroES i
52 abolism is catalyzed by branched-chain alpha-ketoacid dehydrogenase (BCKD).
53    Although deficiency of the branched-chain ketoacid dehydrogenase (BCKDC) and associated elevations
54                         Branched-chain alpha-ketoacid dehydrogenase (BCKDH) catalyzes the critical st
55 ion of the E1alpha subunit of branched-chain ketoacid dehydrogenase (BCKDH).
56 he active site of human branched-chain alpha-ketoacid dehydrogenase (E1b) impede both the decarboxyla
57 iral complementation of branched-chain alpha-ketoacid dehydrogenase activity to identify the gene loc
58  component common to the mitochondrial alpha-ketoacid dehydrogenase and glycine decarboxylase complex
59 he similarity of murine branched chain alpha-ketoacid dehydrogenase and its kinase to the human enzym
60 al similarity of murine branched chain alpha-ketoacid dehydrogenase and its regulation by the complex
61  not use phosphorylated branched chain alpha-ketoacid dehydrogenase as substrate.
62 sulting in the loss of E1 and branched-chain ketoacid dehydrogenase catalytic activities.
63  component of the human branched-chain alpha-ketoacid dehydrogenase complex (BCKDC) has been expresse
64       The mitochondrial branched-chain alpha-ketoacid dehydrogenase complex (BCKDC) is negatively reg
65  The purified mammalian branched-chain alpha-ketoacid dehydrogenase complex (BCKDC), which catalyzes
66 ed by the mitochondrial branched-chain alpha-ketoacid dehydrogenase complex (BCKDC), which is negativ
67 d for regulation of the branched chain alpha-ketoacid dehydrogenase complex by kinase expression duri
68 E2 of the mitochondrial branched-chain alpha-ketoacid dehydrogenase complex can cause the disease.
69 xylase component of the human branched-chain ketoacid dehydrogenase complex comprises two E1alpha (45
70  (E2b) component of the branched-chain alpha-ketoacid dehydrogenase complex forms a cubic scaffold th
71 the human mitochondrial branched-chain alpha-ketoacid dehydrogenase complex.
72 g the E2 subunit of the branched-chain alpha-ketoacid dehydrogenase complex.
73 ts of the mitochondrial branched-chain alpha-ketoacid dehydrogenase complex.
74 e (E1) component of the branched-chain alpha-ketoacid dehydrogenase complex.
75 d (LA) is a cofactor for mitochondrial alpha-ketoacid dehydrogenase complexes and is one of the most
76 arate dehydrogenase and branched chain alpha-ketoacid dehydrogenase complexes and that the apicoplast
77 y a single gene and shared between the alpha-ketoacid dehydrogenase complexes and the Gly decarboxyla
78 n enzyme could restore function to the alpha-ketoacid dehydrogenase complexes in a yeast strain defic
79 yltransferase (SucB) are components of alpha-ketoacid dehydrogenase complexes that are central to int
80 ed for catalysis by multiple mitochondrial 2-ketoacid dehydrogenase complexes, including pyruvate deh
81 tioxidant and an essential cofactor in alpha-ketoacid dehydrogenase complexes, which participate in g
82 s E3 far more weakly relative to other alpha-ketoacid dehydrogenase complexes.
83  encodes the protein incorporated into alpha-ketoacid dehydrogenase complexes.
84 xpression of a putative branched-chain alpha-ketoacid dehydrogenase E1 beta-subunit-encoding gene (Na
85 he L-pyruvate kinase and islet amyloid chain ketoacid dehydrogenase E1a promoter, but it does not aff
86 easome proteolytic system and branched-chain ketoacid dehydrogenase in muscle, along with hepatic glu
87  of the mPK family, rat branched-chain alpha-ketoacid dehydrogenase kinase (BCK).
88 egulation of the BCKDC by the branched-chain ketoacid dehydrogenase kinase has also been implicated i
89  mutations in the gene BCKDK (Branched Chain Ketoacid Dehydrogenase Kinase) in consanguineous familie
90 the human mitochondrial branched chain alpha-ketoacid dehydrogenase multienzyme complex (approximatel
91 m genome contains genes encoding three alpha-ketoacid dehydrogenase multienzyme complexes (KADHs) tha
92                     The branched-chain alpha-ketoacid dehydrogenase phosphatase (BDP) component of th
93 uding those encoding putative branched-chain ketoacid dehydrogenase subunits, is highly expressed dur
94 lutarate dehydrogenase, branched-chain alpha-ketoacid dehydrogenase, and the glycine cleavage system.
95 -ketoglutarate dehydrogenase, branched chain-ketoacid dehydrogenase, and the glycine cleavage system.
96 nched chain aminotransferase, branched chain ketoacid dehydrogenase, glutamate dehydrogenase, and glu
97  of human mitochondrial branched-chain alpha-ketoacid dehydrogenase.
98 oglutarate dehydrogenase, and branched-chain ketoacid dehydrogenase.
99 ta(2) assembly of human branched-chain alpha-ketoacid dehydrogenase.
100  of human mitochondrial branched-chain alpha-ketoacid dehydrogenase/decarboxylase (BCKD).
101 ; Km < 100 microM) for the enzyme were the 2-ketoacid derivatives of valine, leucine, isoleucine, and
102 LipDH and mitochondrial branched chain alpha-ketoacid dihydrolipoamide transacylase in these parasite
103 s of intracellular glutathione, NADPH, alpha-ketoacids, ferredoxin, and thioredoxin indicated that no
104 zes the decarboxylation of these liberated 3-ketoacids, forming the methylketone products.
105  to an effect specific to KIC rather than to ketoacids generally, and argues against an antioxidant m
106 associated elevations in the BCAAs and their ketoacids have been recognized as the cause of maple syr
107              This strategy employs the alpha-ketoacid-hydroxylamine (KAHA) ligation in combination wi
108 atalyzing oxidative decarboxylation of alpha-ketoacids in the Krebs' cycle.
109 -bound enolate intermediates formed from the ketoacids in the presence of the peptide coupling reagen
110 ta-lactones, available via biscyclization of ketoacids including a new asymmetric variant.
111 cei excretes significant amounts of aromatic ketoacids, including indolepyruvate, a transamination pr
112  acid production have motivated the use of 2-ketoacid intermediates for the production of important c
113                      In this case, the alpha-ketoacid is part of the substrate side chain.
114 eterocycle-fused-beta-lactones from N-linked ketoacids is described.
115 lar aldol lactonization of readily available ketoacids leading to the enantioselective synthesis of c
116 (OH)(OCH3) (1a, IC50 = 5.2 microM), an alpha-ketoacid mimic, is less potent.
117 s, glycopeptide I, which contained the alpha-ketoacid moiety at the C-terminus, were synthesized and
118 the fluorine atom at position 6 and the beta-ketoacid moiety.
119 r the products of condensed amino acids with ketoacids or sugars.
120 metabolites upstream of branched-chain alpha-ketoacid oxidation, consistent with reduced BCKD activit
121 uriosus contains four distinct cytoplasmic 2-ketoacid oxidoreductases (ORs) which differ in their sub
122 te is often not detected in studies of alpha-ketoacid oxidoreductases because it rapidly decays.
123 eadily converted to C-terminal peptide alpha-ketoacids, poised for chemoselective amide-forming react
124 ng the cell from toxic effects of imbalanced ketoacid pools.
125 ne) and dioxygen to generate formate and the ketoacid precursor of methionine, 2-keto-4-methylthiobut
126  2-keto-4-methylthiobutanoic acid, the alpha-ketoacid precursor of methionine.
127  fatty acyl-CoA substrates to produce a beta-ketoacid product and initiates the biosynthesis of long
128 7a-d) result from one-pot reactions of alpha-ketoacids, RCOCO(2)H (R = C(6)H(5), CH(3), CH(3)CH(2), t
129 bited when incubated in branched-chain alpha-ketoacids, saturated and unsaturated fatty acids, or 5-a
130 ata are consistent with binding of the alpha-ketoacid substrate by this residue based on the Pseudomo
131 -keto-beta-methyl-n-valerate was used as the ketoacid substrate.
132  decarboxylase that converts the resulting 3-ketoacids to 2-methylketones.
133 ermolecular decarboxylative addition of beta-ketoacids to terminal allenes is reported.
134                                      These 2-ketoacids undergo a wide range of efficient biochemical
135 opsis (Arabidopsis thaliana) also produces 3-ketoacids when recombinantly expressed in E. coli.
136  the production of acyl and aryl acids and 2-ketoacids, which are used for energy conservation.
137 recently developed novel pathways based on 2-ketoacids will be described along with representative ex

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top